17. Implementation Science in HIV Programming

Description There is a substantial gap between innovative approaches in HIV prevention and treatment and their delivery to communities most affected with HIV.  Implementation science addresses the level to which health interventions can fit within real-world public health and clinical service systems. Other aims of the implementation science are to investigate and address major bottlenecks […]

18. Monitoring and Evaluation of HIV Prevention and Treatment Programmes

Background The global epidemic of HIV has led to unprecedented attention and commitment from governmements and the international community to improve access to HIV prevention and treatment. The need to better document the effectiveness of HIV prevention and treatment programmes and to do this with the most robust methods possible is widely recognized. Strategic information […]

19. Evaluation of Interventions in Key Populations at Higher Risk of HIV

Description The increases in funding for HIV prevention and surveillance provided by the Global Fund for AIDS, Tuberculosis and Malaria and the (US) President’s Emergency Plan for AIDS Relief (PEPFAR), increased also the imperative and the opportunities for evaluation of the scaled-up HIV interventions among key populations at higher risk of HIV. HIV transmission can […]

21. HIV Patient Monitoring and ART Cohort Data Analysis

  Description The aim of the training course is to strengthen capacity for antiretroviral treatment (ART) programme monitoring through the use of cohort data with the ultimate goal of improving HIV care and treatment outcomes. The course wil start with introductory presentations on key indicators that are collected to estimate the coverage and impact of […]

22. HIV Epidemic Control: Measuring Progress Toward 2020 and 2030

Description This training workshop will focus on HIV epidemic control and outline what specific programme activities are necessary to achieve it, and which surveillance components should be in place in order that it can be measured.   The workshop will also present current country experiences towards achieving epidemic control. HIV epidemic control is defined as the […]

23. HIV Drug Resistance Prevention and Assessment

  Background Since its introduction, antiretroviral (ARV) drug therapy has dramatically reduced morbidity and mortality associated with HIV infection. The use of combination drug therapies can significantly improve HIV patients’ chances for long-term survival. Unfortunately, the effectiveness of ARV therapy can be markedly reduced by the emergence of drug resistance. Successful treatment of HIV requires […]

24. Getting to Zero: PrEP, treatment for all and differentiated care to reduce incidence and mortality

Background This training workshop describes the major role that pre-exposure prophylaxis (PrEP) to prevent HIV acquisition and treatment as prevention have in reducing HIV incidence and mortality, and bringing the epidemic under control. As of September 2015, WHO recommends that people at substantial risk of HIV infection should be offered PrEP as an additional prevention […]

25. Measuring service coverage and impact of HIV interventions in key and vulnerable populations

Online Training Course

September 28 - October 2, 2020 Background Adequate programmatic service coverage levels among key populations affected by the HIV epidemic, namely female sex workers , people who inject drugs , men who have sex with men ) and transgender persons, is a critical component for achieving HIV epidemic control. Real-time programmatic data are increasingly available […]